Ai2 UK

About:

Ai2 UK develops technology-based products for the prevention of infections on various commonly-used medical devices.

Top Investors: SPARK Impact, MTI Ventures, The North West Fund

Description:

Ai2, Ltd. engages in the development of technology products to prevent infection on various commonly used medical devices. Its products include coated hydrogels for use in catheter, lens, and implant applications; artificial joints to prevent contamination and colonisation of orthopaedic implants by microbes; endotracheal tubes to protect endotracheal tubes from colonisation by microbes; wound dressings to confer anti-infective properties on wound dressing materials; urinary catheters to prevent colonisation by bacteria and other microbes; and vascular catheters. The company's products are human protein-like substances to inhibit bacteria, fungi, and viruses on medical devices, such as urinary catheters, stents, and wound dressings. It serves healthcare companies in the United States and Europe. Ai2, Ltd. was founded in 2004 and is based in Manchester, the United Kingdom.

Total Funding Amount:

2M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2005-01-01

Contact Email:

nicola.cousins(AT)a-i-2.com

Founders:

Curtis Dobson

Number of Employees:

1-10

Last Funding Date:

2012-01-06

IPO Status:

Private

Industries: